Ignite Creation Date:
2024-05-06 @ 8:08 PM
Last Modification Date:
2024-10-26 @ 3:21 PM
Study NCT ID:
NCT06267365
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2024-02-12
Brief Title:
Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis
Sponsor:
NYU Langone Health
Organization:
NYU Langone Health
Study Overview
Official Title:
Predictive Biomarker for Endoscopic Therapy in Chronic Pancreatitis
Status:
RECRUITING
Status Verified Date:
2024-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an observational prospective study to develop predictive biomarkers for pain response in participants with chronic pancreatitis scheduled for endoscopic therapy Participants will undergo baseline assessments including electroencephalography EEG quantitative sensory testing QST and psychosocial questionnaires Response to endoscopic therapy will be assessed at approximately 3 6 12 and 18 months post-procedure using questionnaires
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None